What Do We Know About Rural Mobile Health Clinics? A Scoping Review
Abstract
Rural communities face significant healthcare access barriers that contribute to persistent health disparities. Mobile health clinics (MHCs) have emerged as a promising strategy for expanding healthcare access, yet their effectiveness in rural settings remains understudied. The aim of this review was to examine the literature to determine what is known about access, health outcomes, and the cost-effectiveness of rural MHCs, specifically with regard to their impact on patient access and outcomes, return on investment (ROI)/financial, and program sustainability. We conducted a comprehensive search of peer-reviewed and grey literature sources. Systematic screening yielded 34 documents for full analysis. Thematic analysis was conducted across three domains: patient access, patient outcomes, and ROI/sustainability. All 34 documents provided data on patient access, with common themes including expanded service utilization, multi-service integration, overcoming geographic and transportation barriers, and improved healthcare affordability. Thirty-two documents addressed patient outcomes, reporting improvements in preventive care delivery, chronic disease management, and high patient satisfaction. Twenty-eight documents included ROI/sustainability information, with evidence suggesting cost-effectiveness particularly through emergency department visit avoidance and multi-service integration. Across the literature reviewed, the quality of evidence varied considerably, yet we concluded…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.